Across America

Signed deal - San Francisco

Yuan Yafei, chairman of Jiangsu-based Sanpower Group, shakes hands with Joseph Papa, chairman and CEO of Canada's Valeant Pharmaceuticals International, on Monday at a contract-signing ceremony. Sanpower announced that it has acquired Dendreon,a Seattle-based maker of the prostate cancer vaccine Provenge, from Valeant for $820 million. Provided To China Daily